LLOYZEL FAYE YUNG: Open Payments
NPI 1346990918 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,572 in 96 payments from 12 companies in 2025. Trend: 2023 $297 · 2024 $1,690 · 2025 $2,572
Food & beverage: $2,572
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $675 |
| Otsuka America Pharmaceutical, Inc. | 18 | $608 |
| SK Life Science, Inc. | 11 | $330 |
| ACADIA Pharmaceuticals Inc | 21 | $310 |
| ARGENX US, INC. | 5 | $175 |
| Eisai Inc. | 5 | $165 |
| Lilly USA, LLC | 2 | $101 |
| Lundbeck LLC | 3 | $89 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| UCB, Inc. | 1 | $24 |
Products named: REXULTI, QULIPTA, NUPLAZID, UBRELVY, VYVGART HYTRULO, XCOPRI, VYEPTI, KISUNLA.
Industry payments across NV — which companies pay providers there.
